Fig. 1

Individual changes in (a) the total nasal polyp score (NPS) and (b) the total Sino-Nasal Outcome Test-22 (SNOT-22) score from baseline to 6-month follow-up under dupilumab therapy. Each line represents an individual patient.

Individual changes in (a) the total nasal polyp score (NPS) and (b) the total Sino-Nasal Outcome Test-22 (SNOT-22) score from baseline to 6-month follow-up under dupilumab therapy. Each line represents an individual patient.